| TTM
|
3/31/2026
|
3/31/2025
|
3/31/2024
|
3/31/2023
|
|
|---|---|---|---|---|---|
| Total Revenue
|
128,593 | 212,332 | 175,205 | 23,102 | 38,278 |
| Cost of Revenue
|
-27,452 | -81,979 | -6,954 | -13,471 | -17,266 |
|
Gross Profit
|
101,140 | 130,352 | 168,250 | 9,631 | 21,011 |
|
Operating Income/Expenses
|
-1,319,321 | -1,211,619 | -758,512 | -598,118 | -471,447 |
|
Total Operating Profit/Loss
|
-1,218,181 | -1,081,267 | -590,262 | -588,487 | -450,436 |
| Total Net Finance Income/Expense
|
12,880 | 13,393 | 4,095 | -19,429 | 11 |
| Net Investment Income
|
52,253 | 37,853 | -37,837 | 1,304 | 0 |
| Irregular Income/Expenses
|
2,315 | 1,829 | 0 | -2,024 | 540 |
|
Other Income/Expense, Non-Operating
|
2,529 | 1,489 | -18,007 | -21,318 | 5 |
|
Non-Operating Income/Expenses, Total
|
69,977 | 54,564 | -51,749 | -41,467 | 556 |
|
Pretax Income
|
-1,148,196 | -1,026,699 | -642,014 | -629,953 | -449,878 |
| Provision for Income Tax
|
-3,456 | -3,787 | -3,301 | -2,230 | -2,198 |
|
Net Income from Continuing Operations
|
-1,151,652 | -1,030,486 | -645,315 | -632,183 | -452,076 |
|
Net Income after Extraordinary Items and Discontinued Operations
|
-1,151,653 | -1,030,486 | -645,315 | -632,183 | -452,077 |
|
Non-Controlling/Minority Interests
|
11,807 | 7,845 | 973 | 0 | -- |
|
Net Income after Non-Controlling/Minority Interests
|
-1,139,844 | -1,022,640 | -644,342 | -632,183 | -452,077 |
|
Net Income Available to Common Stockholders
|
-1,139,844 | -1,022,640 | -644,342 | -632,183 | -452,077 |
|
Diluted Net Income Available to Common Stockholders
|
-1,139,844 | -1,022,640 | -644,342 | -632,183 | -452,077 |
| Basic EPS
|
-138.33 | -124.54 | -80.52 | -85.86 | -59.94 |
| Diluted EPS
|
-138.33 | -124.54 | -80.52 | -85.86 | -59.94 |
|
Basic Weighted Average Shares Outstanding
|
8,244.86 | 8,211.34 | 8,002.26 | 7,362.95 | 7,542.32 |
|
Diluted Weighted Average Shares Outstanding
|
8,244.86 | 8,211.34 | 8,002.26 | 7,362.95 | 7,542.32 |
| Income Statement, Supplemental
|
|||||
|
EBIT
|
-1,161,076 | -1,040,092 | -646,109 | -629,998 | -449,889 |
|
EBITDA
|
-955,640 | -955,640 | -569,419 | -559,896 | -371,233 |
|
Normalized EBITDA
|
-919,581 | -919,581 | -530,657 | -559,178 | -372,313 |
|
Normalized Income
|
-1,181,094.82 | -1,028,528 | -642,014 | -627,930 | -452,905.44 |
|
Total Unusual Items
|
-38,337 | 36,059 | 38,762 | 718 | -1,080 |
|
Total Unusual Items Excluding Goodwill
|
-38,337 | 36,059 | 38,762 | 718 | -1,080 |
|
Tax Effect of Unusual Items
|
-8,894.18 | 8,365.69 | 8,992.78 | 166.58 | -250.56 |
3/31/2023 - 6/27/2023
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade